Zacytuj

Alsalem, B. (2019). The diagnostic utility of cancer stem cell marker CD44 in early detection of oral cancer. Dissertation, Thesis Master of Science, University of Maryland, Baltimore. https://archive.hshsl.umaryland.edu/handle/10713/11708 (accessed 20.03.2021).Search in Google Scholar

Ambele, M. A,, van Zyl, A., Pepper, M. S., van Heerden, M. B., Heerden, W. F. P. (2020). Amplification of 3q26.2, 5q14.3, 8q24.3, 8q22.3, and 14q32.33: Are possible common genetic alterations in oral cancer patients. Frontiers Oncol., 10, 1-8.10.3389/fonc.2020.00683720347932426287Search in Google Scholar

Alves, C. S., Yakovlev, S., Medved, L., Konstantopoulos, K. (2009). Bio-molecular characterization of CD44-fibrin(ogen) binding: Distinct molecular requirements mediate binding of standard and variant isoforms of CD44 to immobilized fibrin(ogen). J. Biol Chem.,284 (2), 1177–1189.10.1074/jbc.M805144200261361019004834Search in Google Scholar

Anonymous (2020). GLOBOCAN, 2018. http://gco.iarc.fr (accessed 29.06.2020).Search in Google Scholar

Assimakopoulos, D., Kolettas, E., Patrikakos, G., Evangelou, A. (2002). The role of CD44 in the development and prognosis of head and neck squamous cell carcinomas. Histol. Histopathol., 17 (4), 1269–1281.Search in Google Scholar

Boxberg, M., Götz, C., Haidari S., Dorfner, C., Jesinghaus, M., Drecoll, E., Boskov, M., Wolff, K. D., Weichert, W., Haller, B., Kolk, A. (2018). Immunohistochemical expression of CD44 in oral squamous cell carcinoma in relation to histomorphological parameters and clinicopathological factors. Histopathology, 73 (4), 559–572.10.1111/his.1349629468726Search in Google Scholar

Chen, D., Cun-YuWang, C.-Y (2019). CD44 and ALDH1 immuno-expression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma. Precision Clin. Med., 2 (3), 152–165.10.1093/pcmedi/pbz016677027731598386Search in Google Scholar

Diz, P., Meleti, M., Diniz-Freitas, M., Vescovi, P., Warnakulasuriya, S., Johnson, N. W., Kerr, A. K. (2017). Oral and pharyngeal cancer in Europe: Incidence, mortality and trends as presented to the Global Oral Cancer Forum. Transl. Res. Oral Oncol., 2, 1–310.1177/2057178X17701517Search in Google Scholar

Garcia, A. S., Assao, A., Carvalho, A. L., Soares F. A., Koalski L. P., Oliveira D. T. (2019). The stem cell markers expression CD44v6 and podoplanin in lip cancer: Clinical significance. Virchows Arch., 474 (6), 745–754.10.1007/s00428-019-02539-330770986Search in Google Scholar

Godge, P. Y., Poonja L. S. (2011). Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study. Indian J. Dent Res.,22 (3), 493–49410.4103/0970-9290.8708022048598Search in Google Scholar

Gore, Y., Starlets, D., Maharshak, N., Becker-Herman, S., Kaneyuki, U., Leng, L., Bucala, R., Shachar, I. (2008). Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex. J. Biol. Chem., 283 (5), 2784–2792.10.1074/jbc.M70326520018056708Search in Google Scholar

Groma, V., Kazanceva, A., Krukle, Z. N., Murovska, M. (2012). Oropharyngeal malignant epithelial cell, lymphocyte, and macrophage CD44 surface receptors for hyaluronate are expressed in sustained EBV infection: Immunohistochemical data and EBV DNA tissue indices. Pathol. Res. Practice,208 (9), 518–526.10.1016/j.prp.2012.05.01722770970Search in Google Scholar

Harada, H., Takahashi, M. (2007). CD44-dependeent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2. J. Biol. Chem., 282, 5597–5607.10.1074/jbc.M60835820017170110Search in Google Scholar

Herold-Mende, C., Seiter, S., Born, A. I., Patzelt, E., Schupp, M., Zölle, J., Bosch, F. X., Zöller, M. (1996). Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck. J. Pathol., 179 (1), 66–73.10.1002/(SICI)1096-9896(199605)179:1<66::AID-PATH544>3.0.CO;2-5Search in Google Scholar

Jakovlevs, A., Vanags, A., Gardovskis, J., Strumfa, I. (2019). Molecular classification of diffuse gliomas. Pol. J. Pathol., 70 (4), 246–258.10.5114/pjp.2019.93126Search in Google Scholar

Johnson, P., Ruffell, B. (2009). CD44 and its role in inflammation and inflammatory diseases. Inflamm. Allergy-Drug Targets, 8 (3), 208–220.10.2174/187152809788680994Search in Google Scholar

Kaza, S., Kantheti, L. P., Poosarla, C., Gontu, S. R., Kattappagari, K. K., Baddam, V. R. (2018). A study on the expression of CD44 adhesion molecule in oral squamous cell carcinoma and its correlation with tumor histological grading. J. Orofac. Sci., 10, 42–49.Search in Google Scholar

Khajuria, N., Metgud, R. (2015). Role of bacteria in oral carcinogenesis. Indian J. Dent., 6 (1), 37–43.10.4103/0975-962X.151709Search in Google Scholar

Lindquist, D., Ahrlund-Richter, A., Tarjįn, M., Tot, T., Dalianis, T. (2012). Intense CD44 expression is a negative prognostic factor in tonsillar and base of tongue cancer. Anticancer Res. Act., 32 (1), 153–161.Search in Google Scholar

Miletti-González, K. E., Murphy, K., Kumaran, M. N., Ravindranath, A. K., Wernyj, R. P., Kaur, S., Miles, G. D., Lim, E., Chan, R., Chekmareva, M., Heller, D. S., Foran, D., Chen, W., Reiss, M., Bandera, E. V., Kathleen Scotto, K., Rodríguez-Rodríguez, L. (2012). Identification of function for CD44 intracytoplasmic domain (CD44-ICD): Modulation of matrix metalloproteinase (MMP-9) transcription via novel promoter response element. J. Biol. Chem., 287 (23), 18995–19007.10.1074/jbc.M111.318774Search in Google Scholar

Naga, S. K. S. V., Shekar, P. C., Kattappagari, K. K., Chandra, K. L. P., Reddy, G. S., Reddy, B. V. R. (2019). Expression of cluster differentiation-44 stem cell marker in grades of oral epithelial dysplasia: A preliminary study. J. Oral Maxillofac. Pathol., 23 (2), 203–207.Search in Google Scholar

Nanci A. (2017). Ten Cate’s Oral Histology: Development, Structure and Function.9th edn. St. Luis, Elsevier. 352 pp.Search in Google Scholar

Narayan, T. V., Shilpashree, S. (2016). Meta-analysis on clinicopathologic risk factors of leukoplakias undergoing malignant transformation. J. Oral Maxillofac. Pathol.,20 (3), 354–361.Search in Google Scholar

Negi, L. M., Talegaonkar, S., Jaggi, M., Iqbalz. Z., Khar, R. K. (2012). Role of CD44 in tumour progression and strategies for targeting. J. Drug Target., 20, 561–573.10.3109/1061186X.2012.702767Search in Google Scholar

Ortiz, R. C., Lopes, N. M., Amor, N. G., José, B. P., Schmerling, C. K., Lara V. S., Moyses, R. A., Rodini, C. O. (2018). CD44 and ALDH1 immuno-expression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma. J. Oral Pathol. Med., 47, 740–747.10.1111/jop.12734Search in Google Scholar

Pettersen, J. S., Fuentes-Duculan, J., Suįrez-Farińas, M., Pierson, K. C., Pitts-Kiefer, A., Fan, L., Belkin, D. A., Wang, C. Q. F., Bhuvanendran, S., Johnson-Huang, L. M., Bluth, M. J., Krueger, J. G., Lowes, M. A., Carucci, J. A. (2011). Tumor-associated macrophages in the cutaneous SCC micro-environment are heterogeneously activated. J. Invest. Dermat., 131 (6),1322–1330.10.1038/jid.2011.9Search in Google Scholar

Pisterna, G. V., Siragusa, M. (2007). CD44 presence in inflamed pulp tissue. J. Endod., 33 (10), 1203–1207.10.1016/j.joen.2007.05.022Search in Google Scholar

Puré, E., Oaff, C. A. (2001). A crucial role for CD44 in inflammation. Trends Mol. Med., 7 (5), 213–221.10.1016/S1471-4914(01)01963-3Search in Google Scholar

Reid, P., Marcu, L. G., Olve, I., Moghaddasi, L., Staudacher, A. H., Bezak, E. (2019). Diversity of cancer stem cells in head and neck carcinomas: The role of HPV in cancer stem cell heterogeneity, plasticity and treatment response. Radiother. Oncol.,135, 1–12.10.1016/j.radonc.2019.02.016Search in Google Scholar

Renaud-Vilmer, C., Cavelier-Balloy, B. (2017). Precancerous lesions of the buccal epithelium. Ann. Dermatol. Venereol., 144 (2), 100–108.10.1016/j.annder.2016.07.017Search in Google Scholar

Roye, D. G., Myers, R. B., Brown, D., Poczatek, D. R., Beenken S. W., Grizzle, W. E. (1996). CD44 expression in dysplastic epithelium and squamous-cell carcinoma of the esophagus. Int. J. Cancer, 69, 254–258.10.1002/(SICI)1097-0215(19960822)69:4<254::AID-IJC2>3.0.CO;2-WSearch in Google Scholar

Speight, P. M., Khurram, S. A., Kujan, O. (2018). Oral potentially malignant disorders: Risk of progression to malignancy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol., 125 (6), 612–627.10.1016/j.oooo.2017.12.011Search in Google Scholar

Sundberg, J., Korytowska, M., Holmberg, E., Bratel, J., Wallström, M., Kjellström, E., Blomgren, J., Kovįcs, A., Öhman, J., Sand, L., Hirsch, J.-M., Giglio, D., Kjeller, G., Bengt Hasséus, B. (2019). Recurrence rates after surgical removal of oral leukoplakia: A prospective longitudinal multi-centre study. PLoS One, 14 (12), e0225682.10.1371/journal.pone.0225682Search in Google Scholar

Tamatani, T., Takamaru, N., Ohe, G., Akita, K., Nakagawa, T., Miyamoto, Y. (2018). Express of CD44, CD44v9, ABCG2, CD24, Bmi-1 and ALDH1 instage I and II oral squamous cell carcinoma and their association with clinicopathological factors. Oncol. Lett., 16 (1),1133–1140.Search in Google Scholar

Wang, S. J., Wong, G, de Heer G. A. M., Xia W, Bourguignon, L.Y. (2009). CD44 variant isoforms in head and neck squamous cell carcinoma progression. The Laryngoscope, 119 (8), 1518–1530.10.1002/lary.20506Search in Google Scholar

Warnakulasuriya S. (2009). Global epidemiology of oral and oropharyngeal cancer. Oral. Oncol., 45 (4–5), 309–316.10.1016/j.oraloncology.2008.06.002Search in Google Scholar

Wielenga, V. J. M., Heider, K-H., Offerhaus, G. J. A., Adolf, G. R., Berg, F. M., Punta, H., Herrlich, P., Steven T. Pals, S. T. (1993). Advances in brief expression of CD44 variant proteins in human colorectal cancer is related to tumor progression. Cancer Research, 53, 4754–4756.Search in Google Scholar

eISSN:
1407-009X
Język:
Angielski
Częstotliwość wydawania:
6 razy w roku
Dziedziny czasopisma:
General Interest, Mathematics, General Mathematics